We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.36B
AUM Growth
+$457M
Cap. Flow
-$178M
Cap. Flow %
-2.42%
Top 10 Hldgs %
26.1%
Holding
2,906
New
66
Increased
422
Reduced
1,573
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 25.69%
2 Consumer Discretionary 12.47%
3 Healthcare 12.1%
4 Financials 11.43%
5 Communication Services 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRT
2376
DELISTED
HireRight Holdings Corporation
HRT
$118K ﹤0.01%
+7,356
New +$123K
IPI icon
2377
Intrepid Potash
IPI
$484M
$118K ﹤0.01%
2,753
NEX
2378
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$118K ﹤0.01%
33,126
-2,002
-6% -$8.38K
UFPT icon
2379
UFP Technologies
UFPT
$2.48B
$117K ﹤0.01%
1,670
-663
-28% -$43.9K
PRTY
2380
DELISTED
Party City Holdco Inc.
PRTY
$117K ﹤0.01%
21,005
-707
-3% -$4.68K
PHAT icon
2381
Phathom Pharmaceuticals
PHAT
$743M
$117K ﹤0.01%
5,942
MCFE
2382
DELISTED
McAfee Corp. Class A Common Stock
MCFE
$117K ﹤0.01%
4,529
+720
+19% +$17.4K
IAS
2383
DELISTED
Integral Ad Science
IAS
$116K ﹤0.01%
5,239
DYN icon
2384
Dyne Therapeutics
DYN
$4.85B
$116K ﹤0.01%
9,762
+2,725
+39% +$38.3K
HLX icon
2385
Helix Energy Solutions
HLX
$1.49B
$116K ﹤0.01%
37,188
+2,458
+7% +$9.06K
CONN
2386
DELISTED
Conn's Inc.
CONN
$116K ﹤0.01%
4,929
CRIS icon
2387
Curis
CRIS
$3.91M
$116K ﹤0.01%
61
+16
+36% +$38.1K
MVBF icon
2388
MVB Financial
MVBF
$397M
$116K ﹤0.01%
2,785
EQBK icon
2389
Equity Bancshares
EQBK
$1.07B
$115K ﹤0.01%
3,402
-450
-12% -$15.2K
RYZ
2390
Ryerson Holding Corp
RYZ
$1.5B
$115K ﹤0.01%
4,424
MCRB icon
2391
Seres Therapeutics
MCRB
$45M
$115K ﹤0.01%
691
+193
+39% +$30.7K
SPNE
2392
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$115K ﹤0.01%
8,432
HLF icon
2393
Herbalife
HLF
$1.28B
$115K ﹤0.01%
2,804
-99
-3% -$4.12K
IBRX icon
2394
ImmunityBio
IBRX
$8.11B
$115K ﹤0.01%
18,874
-329
-2% -$2.47K
CGEM icon
2395
Cullinan Oncology
CGEM
$1.26B
$114K ﹤0.01%
7,420
DV icon
2396
DoubleVerify
DV
$2.04B
$114K ﹤0.01%
3,440
+2,402
+231% +$80.1K
ARAY icon
2397
Accuray
ARAY
$32.9M
$114K ﹤0.01%
23,994
-1,073
-4% -$5.17K
UFCS icon
2398
United Fire Group
UFCS
$1.38B
$114K ﹤0.01%
4,930
DICE
2399
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$114K ﹤0.01%
+4,514
New +$132K
EBTC
2400
DELISTED
Enterprise Bancorp
EBTC
$114K ﹤0.01%
2,537

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 Portfolio in Review

As of Q4 2021, Metropolitan Life Insurance Company (MetLife) held 2,906 positions worth $7.36B, up 6.6% from $6.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 filing shows 66 new, 422 increased, 1,573 reduced and 124 closed positions. Its largest new stake was Kyndryl: 32,951 shares worth $596K. The largest sale was iShares Russell 1000 Growth ETF, an estimated $18.3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2021 buy was Kyndryl: 32,951 shares worth $596K.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $34.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $18.3M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Kansas City Southern in Q4 2021, selling an estimated $3.18M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $7.36B portfolio in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 66 new positions and closed 124 in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.6% quarter-over-quarter to $7.36B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.